Clinical Trial Update: Corneal Sensitivity Cross-linking Keratoconus [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update noting the completion of Phase 2 and Phase 3 studies evaluating riboflavin-assisted corneal cross-linking for keratoconus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• Riboflavin-assisted corneal cross-linking (riboflavin)

Snippet

Sponsor: Instituto de Olhos de Goiania | Conditions: Keratoconus | Phase 2, Phase 3 | Status: COMPLETED